Castle Biosciences (CSTL) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free CSTL Stock Alerts $19.20 +0.36 (+1.91%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Castle Biosciences Short Interest DataCurrent Short Volume1,430,000 sharesPrevious Short Volume1,420,000 sharesChange Vs. Previous Month+0.70%Dollar Volume Sold Short$31.67 millionShort Interest Ratio / Days to Cover5.7Last Record DateMarch 31, 2024Outstanding Shares27,450,000 sharesPercentage of Shares Shorted5.21%Today's Trading Volume139,713 sharesAverage Trading Volume237,002 sharesToday's Volume Vs. Average59% Short Selling Castle Biosciences ? Sign up to receive the latest short interest report for Castle Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCSTL Short Interest Over TimeCSTL Days to Cover Over TimeCSTL Percentage of Float Shorted Over Time Ad InvestorPlaceYou’re invited: Biggest crypto event of 2024During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Castle Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,430,000 shares $31.67 million +0.7%N/A5.7 $22.15 3/15/20241,420,000 shares $26.77 million +17.4%N/A5.6 $18.85 2/29/20241,210,000 shares $21.85 million -3.2%N/A4.6 $18.06 2/15/20241,250,000 shares $31.10 million +0.8%5.0%5.5 $24.88 1/31/20241,240,000 shares $28.62 million +29.3%5.0%5.4 $23.08 1/15/2024958,800 shares $19.20 million +19.8%3.8%3.7 $20.03 Get the Latest News and Ratings for CSTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Castle Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023800,300 shares $17.27 million -18.1%3.2%2.9 $21.58 12/15/2023977,300 shares $19.61 million -17.2%3.9%3.6 $20.07 11/30/20231,180,000 shares $23.59 million -9.2%4.7%4.7 $19.99 11/15/20231,300,000 shares $24.99 million -9.1%5.2%5.2 $19.22 10/31/20231,430,000 shares $22.34 million +28.8%N/A5.6 $15.62 10/15/20231,110,000 shares $13.74 million +11.6%N/A4 $12.38 9/30/2023994,800 shares $16.80 million +19.4%N/A3 $16.89 9/15/2023833,200 shares $14.41 million +16.2%N/A1.5 $17.30 8/31/2023716,800 shares $14.29 million -3.6%N/A1.1 $19.93 8/15/2023743,500 shares $13.97 million -14.1%N/A0.9 $18.79 7/31/2023865,500 shares $14.58 million +1.3%N/A1 $16.85 7/15/2023854,500 shares $13.63 million +32.2%N/A1.1 $15.95 6/30/2023646,400 shares $8.87 million -26.8%N/A0.9 $13.72 6/15/2023883,200 shares $11.83 million +16.4%N/A2 $13.40 5/31/2023758,600 shares $18.53 million -13.6%N/A2 $24.43 5/15/2023878,100 shares $20.69 million -11.0%N/A6 $23.56 4/30/2023986,400 shares $22.32 million +0.7%N/A6.9 $22.63 4/15/2023979,400 shares $22.11 million -4.9%N/A6.8 $22.58 3/31/20231,030,000 shares $23.40 million -2.8%N/A7.1 $22.72 3/15/20231,060,000 shares $24.01 million +23.0%N/A6.8 $22.65 2/28/2023862,000 shares $21.71 million -25.0%N/A5.6 $25.18 2/15/20231,150,000 shares $30.94 million +4.6%N/A7.8 $26.90 1/31/20231,100,000 shares $29.79 million -2.7%N/A6.4 $27.08 1/15/20231,130,000 shares $30.75 million -5.0%N/A6 $27.21 12/30/20221,190,000 shares $28.01 million +5.3%4.9%5.9 $23.54 12/15/20221,130,000 shares $27.90 million +5.6%4.6%5.6 $24.69 11/30/20221,070,000 shares $25.24 million +0.9%4.4%5.3 $23.59 11/15/20221,060,000 shares $24.41 million -9.4%4.3%5.3 $23.03 10/31/20221,170,000 shares $29.86 million -10.0%4.8%5.9 $25.52 10/15/20221,300,000 shares $28.63 million +4.0%5.3%6.6 $22.02 9/30/20221,250,000 shares $32.60 million +7.8%5.3%6.3 $26.08 9/15/20221,160,000 shares $32.97 million -1.7%4.9%4.9 $28.42 8/31/20221,180,000 shares $34.22 million -1.7%5.0%4.5 $29.00 8/15/20221,200,000 shares $40.19 million -17.2%5.1%4.1 $33.49You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. CSTL Short Interest - Frequently Asked Questions What is Castle Biosciences' current short interest? Short interest is the volume of Castle Biosciences shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 1,430,000 shares of CSTL short. Learn More on Castle Biosciences' current short interest. What is a good short interest ratio for Castle Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSTL shares currently have a short interest ratio of 6.0. Learn More on Castle Biosciences's short interest ratio. Which institutional investors are shorting Castle Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Castle Biosciences: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Castle Biosciences' short interest increasing or decreasing? Castle Biosciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,430,000 shares, an increase of 0.7% from the previous total of 1,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Castle Biosciences' short interest compare to its competitors? Here is how the short interest of companies compare to Castle Biosciences: Fulgent Genetics, Inc. (3.02%), CareDx, Inc (10.48%), Sera Prognostics, Inc. (1.15%), Genetron Holdings Limited (0.08%), Biodesix, Inc. (1.12%), Viridian Therapeutics, Inc. (15.09%), Personalis, Inc. (2.64%), Renalytix Plc (1.59%), Exagen Inc. (0.26%), DermTech, Inc. (10.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Castle Biosciences stock? Short selling CSTL is an investing strategy that aims to generate trading profit from Castle Biosciences as its price is falling. CSTL shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Castle Biosciences? A short squeeze for Castle Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSTL, which in turn drives the price of the stock up even further. How often is Castle Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSTL, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: FLGT Short Interest Data CDNA Short Interest Data SERA Short Interest Data GTH Short Interest Data BDSX Short Interest Data VRDN Short Interest Data PSNL Short Interest Data RNLX Short Interest Data XGN Short Interest Data DMTK Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CSTL) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research